International collaborative proficiency study of Human Papillomavirus type 16 serology.


Autoria(s): Eklund C.; Unger E.R.; Nardelli-Haefliger D.; Zhou T.; Dillner J.
Data(s)

2012

Resumo

We performed an international proficiency study of Human Papillomavirus (HPV) type 16 serology. A common methodology for serology based on virus-like particle (VLP) ELISA was used by 10 laboratories in 6 continents. The laboratories used the same VLP reference reagent, which was selected as the most stable, sensitive and specific VLP preparation out of VLPs donated from 5 different sources. A blinded proficiency panel consisting of 52 serum samples from women with PCR-verified HPV 16-infection, 11 control serum samples from virginal women and the WHO HPV 16 International Standard (IS) serum were distributed. The mean plus 3 standard deviations of the negative control serum samples was the most generally useful "cut-off" criterion for distinguishing positive and negative samples. Using sensitivity of at least 50% and a specificity of 100% as proficiency criteria, 6/10 laboratories were proficient. In conclusion, an international Standard Operating Procedure for HPV serology, an international reporting system in International Units (IU) and a common "cut-off" criterion have been evaluated in an international HPV serology proficiency study.

Identificador

http://serval.unil.ch/?id=serval:BIB_B9B066FBBAD8

isbn:1873-2518 (Electronic)

pmid:22079074

doi:10.1016/j.vaccine.2011.10.096

isiid:000299971800028

Idioma(s)

en

Fonte

Vaccine, vol. 30, no. 2, pp. 294-299

Tipo

info:eu-repo/semantics/article

article